This document shares recent findings from the AQUA randomised controlled trial and the Transforming Attention Deficit Hyperactivity Disorder (ADHD) demonstrator project.
The intention is to encourage the adoption of the QbTest to benefit patients through reduced delay to diagnosis, whilst saving NHS time and money. The document covers the following sections:
- What is QbTest?
- What did we find?
- What do these findings mean for you?
- Alignment with STP priorities
- Experience and cost
- Next steps